Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Potential Extensions of the US FRAX Algorithm.

Melton LJ 3rd, Atkinson EJ, Achenbach SJ, Kanis JA, Therneau TM, Johansson H, Khosla S, Amin S.

J Osteoporos. 2012;2012:528790. doi: 10.1155/2012/528790. Epub 2012 Aug 15.

2.

Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.

Donaldson MG, Palermo L, Ensrud KE, Hochberg MC, Schousboe JT, Cummings SR.

J Bone Miner Res. 2012 Aug;27(8):1804-10. doi: 10.1002/jbmr.1625.

3.

Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men.

Yu R, Leung J, Woo J.

J Am Med Dir Assoc. 2014 Dec;15(12):918-23. doi: 10.1016/j.jamda.2014.07.011. Epub 2014 Sep 24.

PMID:
25262197
4.

Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration.

Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA; Manitoba Bone Density Program.

J Bone Miner Res. 2010 Nov;25(11):2350-8. doi: 10.1002/jbmr.123.

5.

The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort?

Sornay-Rendu E, Munoz F, Delmas PD, Chapurlat RD.

J Bone Miner Res. 2010 Oct;25(10):2101-7. doi: 10.1002/jbmr.106.

6.

Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus.

Lee JJ, Aghdassi E, Cheung AM, Morrison S, Cymet A, Peeva V, Neville C, Hewitt S, DaCosta D, Pineau C, Pope J, Fortin PR.

J Rheumatol. 2012 Jul;39(7):1378-84. doi: 10.3899/jrheum.111589. Epub 2012 Jun 1.

PMID:
22660811
7.

Fracture burden in relation to low bone mineral density and FRAX(®) probability.

Leslie WD, Morin S.

J Clin Densitom. 2011 Jul-Sep;14(3):279-85. doi: 10.1016/j.jocd.2011.04.010. Epub 2011 Jul 1.

PMID:
21723761
8.

Does osteoporosis therapy invalidate FRAX for fracture prediction?

Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA; Manitoba Bone Density Program.

J Bone Miner Res. 2012 Jun;27(6):1243-51. doi: 10.1002/jbmr.1582.

9.

Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.

Trémollieres FA, Pouillès JM, Drewniak N, Laparra J, Ribot CA, Dargent-Molina P.

J Bone Miner Res. 2010 May;25(5):1002-9. doi: 10.1002/jbmr.12.

10.

Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures.

Lalmohamed A, Welsing PM, Lems WF, Jacobs JW, Kanis JA, Johansson H, De Boer A, De Vries F.

Osteoporos Int. 2012 Mar;23(3):861-9. doi: 10.1007/s00198-011-1852-2. Epub 2011 Nov 26.

11.

Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX.

McCloskey EV, Johansson H, Oden A, Austin M, Siris E, Wang A, Lewiecki EM, Lorenc R, Libanati C, Kanis JA.

J Bone Miner Res. 2012 Jul;27(7):1480-6. doi: 10.1002/jbmr.1606.

12.

Probability of fractures predicted by FRAX® and observed incidence in the Spanish ECOSAP Study cohort.

González-Macías J, Marin F, Vila J, Díez-Pérez A.

Bone. 2012 Jan;50(1):373-7. doi: 10.1016/j.bone.2011.11.006. Epub 2011 Nov 20.

PMID:
22129640
13.

Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.

Siris ES, Baim S, Nattiv A.

Postgrad Med. 2010 Jan;122(1):82-90. doi: 10.3810/pgm.2010.01.2102. Review.

PMID:
20107292
14.

FRAX underestimates fracture risk in patients with diabetes.

Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA.

J Bone Miner Res. 2012 Feb;27(2):301-8. doi: 10.1002/jbmr.556.

15.

[Usefulness of FRAX and future issues in women's health].

Hashimoto K, Ishitani K, Ohta H.

Clin Calcium. 2009 Dec;19(12):1742-8. doi: CliCa091217421744. Review. Japanese.

PMID:
19949265
16.

Absolute fracture risk assessment using lumbar spine and femoral neck bone density measurements: derivation and validation of a hybrid system.

Leslie WD, Lix LM; Manitoba Bone Density Program.

J Bone Miner Res. 2011 Mar;26(3):460-7. doi: 10.1002/jbmr.248.

17.

[Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].

Lippuner K.

Ther Umsch. 2012 Mar;69(3):207-13. doi: 10.1024/0040-5930/a000275. German.

PMID:
22403115
18.

Measurement of cortical porosity of the proximal femur improves identification of women with nonvertebral fragility fractures.

Ahmed LA, Shigdel R, Joakimsen RM, Eldevik OP, Eriksen EF, Ghasem-Zadeh A, Bala Y, Zebaze R, Seeman E, Bjørnerem Å.

Osteoporos Int. 2015 Aug;26(8):2137-46. doi: 10.1007/s00198-015-3118-x. Epub 2015 Apr 16.

19.

[Utility of Fracture Risk Assessment Tool (FRAX)].

Fujiwara S.

Nihon Rinsho. 2011 Jul;69(7):1239-42. Japanese.

PMID:
21774364
20.

Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.-Conformity between methods and their clinical utility.

Pluskiewicz W, Adamczyk P, Franek E, Leszczynski P, Sewerynek E, Wichrowska H, Napiorkowska L, Kostyk T, Stuss M, Stepien-Klos W, Golba KS, Drozdzowska B.

Bone. 2010 Jun;46(6):1661-7. doi: 10.1016/j.bone.2010.02.012. Epub 2010 Feb 13.

PMID:
20156606

Supplemental Content

Support Center